Clinical Trial Update: Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

View source ↗

Summary

Real-world study evaluating safety (adverse events) and changes in disease activity with oral upadacitinib in Chinese adolescents and adults with atopic dermati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (Rinvoq) (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis (AD) | Status: ACTIVE_NOT_RECRUITING